2024
DOI: 10.1016/s1473-3099(23)00815-0
|View full text |Cite
|
Sign up to set email alerts
|

Persistent SARS-CoV-2 infection: significance and implications

Heather M Machkovech,
Anne M Hahn,
Jacqueline Garonzik Wang
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(8 citation statements)
references
References 60 publications
1
7
0
Order By: Relevance
“…The results presented above add to an accumulating body of evidence suggesting that in a small number of cases SARS-CoV-2 can form a reservoir in different anatomical compartments [48][49][50] and that in many cases this reservoir is not always detectable via conventional SARS-CoV-2 testing [48] . This highlights that further investigation on how these tissue reservoirs contribute to SARS-CoV-2 persistence is needed.…”
Section: Discussionsupporting
confidence: 55%
See 1 more Smart Citation
“…The results presented above add to an accumulating body of evidence suggesting that in a small number of cases SARS-CoV-2 can form a reservoir in different anatomical compartments [48][49][50] and that in many cases this reservoir is not always detectable via conventional SARS-CoV-2 testing [48] . This highlights that further investigation on how these tissue reservoirs contribute to SARS-CoV-2 persistence is needed.…”
Section: Discussionsupporting
confidence: 55%
“…These observations also have implications for the care of immunocompromised individuals as a negative SARS-CoV-2 test is not a guarantee that an infection has cleared. Alternative specimen types, such as stool should be considered [50] and any SARS-CoV-2 positive samples from immunocompromised patients should be sequenced to distinguish between acute and long-term SARS-CoV-2 infections.…”
Section: Discussionmentioning
confidence: 99%
“…We and others have reported such clinical cases -patients who have received B-cell targeting therapies and were currently on extended cortical steroids treatment (affecting also the T cell activity) would experience prolonged respiratory symptoms following SARS-CoV-2 infection. 4 Clinical observations underscore the lingering respiratory symptoms following SARS-CoV-2 infection in patients subjected to such therapies, further emphasizing the urgent need for clinical research and therapeutic interventions tailored to this demographic.…”
Section: Commentarymentioning
confidence: 99%
“…In these patients, the limited inflammatory response against viral infection leads to persisting symptoms such as fever and shortness of breath; on the other hand, the immune response is not strong enough to clear the virus, leading to the lesions being migratory in radiological examinations. 4 We propose to describe this scenario as chronic active SARS-CoV-2 infection, particularly in B-cell immunodeficiency (CASBI). The chronic here describes the persistent detection of SARS-CoV-2 in the respiratory tract samples and prolonged viral shedding, usually for more than 30-60 days.…”
Section: Commentarymentioning
confidence: 99%
“…Over the past three years, the spread and severity of coronavirus disease 19 (COVID-19) have declined. However, a rare and intriguing manifestation of SARS-CoV-2 infection, known as ‘prolonged SARS-CoV-2 infection’ is garnering attention [ 1 ]. This condition encompasses cases of SARS-CoV-2 infection that extend beyond the typical duration of viral shedding in the respiratory tract, which is usually 17–21 days, along with persistent clinical symptoms [ 2 3 4 5 ].…”
Section: Introductionmentioning
confidence: 99%